Company news

Shield Therapeutics PLC news in 2023

Shield Therapeutics PLC's news releases, calls and decks from 2023, newest first.

View company

Q3 2023 U.S. Commercial Highlights

December 7, 2023

Abstract to be presented at Healthcare Conference

October 20, 2023

Chief Financial Officer Transition

October 12, 2023

Result of REX Retail Offer

October 3, 2023

Successful completion of US$6.1m Equity Fundraise

September 28, 2023

Notice of Results and Change in reporting currency

September 6, 2023

Holding(s) in Company

July 24, 2023

Business Update and U.S. Q2 2023 Highlights

July 20, 2023

Results of 2023 Annual General Meeting

June 28, 2023

Grant of share options to the CEO

June 6, 2023

2022 Annual Report and 2023 AGM Notice

May 19, 2023

Rule 2.9 Announcement and TVR Update

May 9, 2023

Business Update and Unaudited Results

April 27, 2023

Appointment of Chief Commercial Officer

April 5, 2023

Block Listing 6 Monthly Return

March 31, 2023

Price Monitoring Extension

March 15, 2023

Total Voting Rights Update

February 28, 2023

Second Price Monitoring Extn

February 17, 2023

Full Year Trading Update

February 9, 2023

Hardman & Co Q&A on Shield Therapeutics...

January 23, 2023

Hardman & Co Research: Shield Therapeutics...

January 13, 2023

Partial AOP Loan Conversion

January 9, 2023

Result of General Meeting & Open Offer

January 5, 2023

Calls in 2023

Decks in 2023